Harrow HROW
NASDAQ HROW
$30.49 -0.12 (-0.39%)
As of: Oct 2, 2026 · 11:28 AM EDT

Harrow (HROW) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Harrow (HROW) posted Depreciation & Amortization (CF) of $460,000 for Q2 2026, down 7.3% from $496,000 a year earlier but up 1.1% from the prior quarter.

Analysis

Harrow (HROW) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Harrow was $1.87 million, down 3.0% year-over-year; for FY2025, it came in at $1.92 million, up 3.5% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for three consecutive years, with a five-year compound annual growth rate of 0.4% (FY2020 to FY2025).
  • In prior years, Harrow's Depreciation & Amortization (CF) was $1.85 million in FY2024 (+20.9%), $1.53 million in FY2023 (+3.6%), $1.48 million in FY2022 (-14.0%) and $1.72 million in FY2021 (-8.7%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $247,000 in Q3 2022 to a high of $497,000 in Q3 2024 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last four quarters, with growth averaging 4.5% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2023, with growth of 64.0%; the weakest was Q3 2022, with a decline of 38.1%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $455,000 (Q1 2026), $464,000 (Q4 2025) and $490,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Harrow 1.15 Bn 828.41 Mn 50.36 Mn 460,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 460,000.00
Mar 31, 2026 455,000.00
Dec 31, 2025 464,000.00
Sep 30, 2025 490,000.00
Jun 30, 2025 496,000.00
Mar 31, 2025 465,000.00
Dec 31, 2024 468,000.00
Sep 30, 2024 497,000.00
Jun 30, 2024 453,000.00
Mar 31, 2024 432,000.00
Dec 31, 2023 435,000.00
Sep 30, 2023 405,000.00
Jun 30, 2023 398,000.00
Mar 31, 2023 292,000.00
Dec 31, 2022 387,000.00
Sep 30, 2022 247,000.00
Jun 30, 2022 424,000.00
Mar 31, 2022 419,000.00
Dec 31, 2021 442,000.00
Sep 30, 2021 399,000.00
API Access

Harrow Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=HROW&period=max&api_key=YOUR_API_KEY